John R. Hepler

Dr. John R. Hepler


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1999 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
JHJohn R. Hepler
John R. Hepler

1 February 2016 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
KGKyle J. Gerber
Kyle J. Gerber
KSKatherine E. Squires
Katherine E. Squires
JHJohn R. Hepler
John R. Hepler
The regulator of G protein signaling (RGS) family of proteins serves critical roles in G protein-coupled receptor (GPCR) and heterotrimeric G protein signal transduction. RGS proteins are best understood as negative regulators of GPCR/G protein signaling. They achieve this by acting as GTPase activating proteins (GAPs) for Gα subunits and accelerating the turnoff of G protein signaling. Many RGS proteins also bind additional signaling partners that either regulate their functions or enable them to regulate other important signaling events. At neuronal synapses, GPCRs, G proteins, and RGS proteins work in coordination to regulate key aspects of neurotransmitter release, synaptic transmission, and synaptic plasticity, which are necessary for central nervous system physiology and behavior. Accumulating evidence has revealed key roles for specific RGS proteins in multiple signaling pathways at neuronal synapses, regulating both pre- and postsynaptic signaling events and synaptic plasticity. Here, we review and highlight the current knowledge of specific RGS proteins (RGS2, RGS4, RGS7, RGS9-2, and RGS14) that have been clearly demonstrated to serve critical roles in modulating synaptic signaling and plasticity throughout the brain, and we consider their potential as future therapeutic targets.

1 March 2010 in Cellular Signalling
Verified
Journal Article
Closed access
FSFeng-Jue Shu
Feng-Jue Shu
SRSuneela Ramineni
Suneela Ramineni
JHJohn R. Hepler
John R. Hepler

1 November 2000 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
JRJeremy J. Rose
Jeremy J. Rose
JTJackie B. Taylor
Jackie B. Taylor
JSJing Shi
Jing Shi
MCMark I. Cockett
Mark I. Cockett
PJPhilip G. Jones
Philip G. Jones
JHJohn R. Hepler
John R. Hepler

1 November 2001 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
SHSusanne Hollinger
Susanne Hollinger
JTJackie B. Taylor
Jackie B. Taylor
EGErinn H. Goldman
Erinn H. Goldman
JHJohn R. Hepler
John R. Hepler

1 June 2010 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
KMKelly L. McCoy
Kelly L. McCoy
STStephen F. Traynelis
Stephen F. Traynelis
JHJohn R. Hepler
John R. Hepler
The protease-activated receptors (PAR1 and PAR2) are unusual G protein-coupled receptors that are activated by distinct serine proteases and are coexpressed in many different cell types. Limited recent evidence suggests these closely related receptors regulate different physiological outputs in the same cell, although little is known about the comparative signaling pathways used by these receptors. Here we report that PAR1 and PAR2 couple to overlapping and distinct sets of G proteins to regulate receptor-specific signaling pathways involved in cell migration. In functionally PAR-null COS-7 cells, ectopically expressed PAR1 and PAR2 both form stable complexes with Gαq, Gα11, Gα14, Gα12, and Gα13. It is surprising that PAR1 but not PAR2 coupled to Gαo, Gαi1, and Gαi2. Consistent with these observations, PAR1 and PAR2 stimulation of inositol phosphate production and RhoA activation was blocked by specific inhibitors of Gq/11 and G12/13 signaling, respectively. Both receptors stimulated extracellular signal-regulated kinase (ERK) 1/2 phosphorylation, but only PAR1 inhibited adenylyl cyclase activity, and pertussis toxin blocked PAR1 effects on both adenylyl cyclase and ERK1/2 signaling. Neu7 astrocytes express native PAR1 and PAR2 receptors that activate inositol phosphate, RhoA, and ERK1/2 signaling. However, only PAR1 inhibited adenylyl cyclase activity. PAR1 and PAR2 also stimulate Neu7 cell migration. PAR1 effects on ERK1/2 phosphorylation and cell migration were blocked both by pertussis toxin and by the mitogen-activated protein kinase kinase/ERK inhibitor [1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126)], whereas PAR2 effects were only blocked by U0126. These studies demonstrate that PAR1 and PAR2 physically and functionally link to overlapping and distinct profiles of G proteins to differentially regulate downstream signaling pathways and cell physiology.